Cargando…
B Quiet: Autoantigen-Specific Strategies to Silence Raucous B Lymphocytes and Halt Cross-Talk with T Cells in Type 1 Diabetes
Islet autoantibodies are the primary biomarkers used to predict type 1 diabetes (T1D) disease risk. They signal immune tolerance breach by islet autoantigen-specific B lymphocytes. T-B lymphocyte interactions that lead to expansion of pathogenic T cells underlie T1D development. Promising strategies...
Autores principales: | Felton, Jamie L., Conway, Holly, Bonami, Rachel H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824835/ https://www.ncbi.nlm.nih.gov/pubmed/33418839 http://dx.doi.org/10.3390/biomedicines9010042 |
Ejemplares similares
-
Jo-1 autoantigen-specific B cells are skewed towards distinct functional B cell subsets in anti-synthetase syndrome patients
por: Young-Glazer, Jennifer, et al.
Publicado: (2021) -
High-Throughput Detection of Autoantigen-Specific B Cells Among Distinct Functional Subsets in Autoimmune Donors
por: Joosse, Bryan A., et al.
Publicado: (2021) -
“Dead Cells Talking”: The Silent Form of Cell Death Is Not so Quiet
por: Jäger, Richard, et al.
Publicado: (2012) -
Book Review: Quiet: The Power of Introverts in a World That Can't Stop Talking
por: Clack, Lesley A.
Publicado: (2017) -
Pathogen‐specific B‐cell receptors drive chronic lymphocytic leukemia by light‐chain‐dependent cross‐reaction with autoantigens
por: Jiménez de Oya, Nereida, et al.
Publicado: (2017)